
PFE Stock Down 2%, Pfizer Reports Profitable Q4, Works on Adapting Vaccine to New Strains
Pfizer raised its earnings guidance for the 2021 fiscal year noting that its revenues will range between $59.4 billion and $61.4 billion, with vaccine sales taking a prominent role in the achievement.